Once You’ve Prescribed TEPEZZA, the Horizon By Your Side Team Is Here to Assist Your Patient Every Step of the Way

CONNECT: Your patient will be paired with a Patient Access Liaison who will support your patient throughout their treatment when they need it

COORDINATE: The Horizon By Your Side team will work with your patient and healthcare team to make sure non-medical, logistical efforts are coordinated properly

CHAMPION: The Patient Access Liaison will be the point of contact to work with your patient’s unique needs and help them build confidence throughout their treatment

The logistics of starting treatment with TEPEZZA may initially seem new and unfamiliar. Horizon By Your Side offers a wide array of patient-focused services like:

Patient support icon Patient support icon Patient support icon

Patient support

Infusion logistics icon Infusion logistics icon Infusion logistics icon

Infusion logistics assistance

Financial assistance icon Financial assistance icon Financial assistance icon

Financial assistance

Insurance benefits icon Insurance benefits icon Insurance benefits icon

Insurance benefits investigation

Explore everything Horizon By Your Side offers to your appropriate patients


We believe patients should pay the lowest amount possible

Paying for treatment shouldn’t get in the way of health. That’s why the Horizon By Your Side team is diligent in exploring all options to help your patient.*

  • Does your patient have commercial insurance?

    They may qualify for $0 co-pay for both the cost of the medication and the intravenous (IV) infusion

  • Does your patient have government insurance, like Medicare?

    Independent foundation support might be an option

  • Who can help educate my patients on the insurance approval process?

    Once your treatment plan is set in place, the Patient Access Liaison can help talk with your patient about the insurance approval process and what potential out-of-pocket treatment costs may be

  • Is your patient uninsured?

    Contact the Horizon By Your Side team at 1-833-5-TEPEZZA (1-833-583-7399) to discuss support options

    Contact the Horizon By Your Side team at 1-833-5-TEPEZZA
    (1-833-583-7399) to discuss support options

Please note that independent foundations establish, administer, and implement the funds, which are separate and apart from Horizon.

Patient services icon Patient services icon

Learn more about personalized support for your patients at HorizonByYourSide.com


Getting started

Start patients off on the right track with their TEPEZZA treatment

If TEPEZZA is right for your patient, initiate enrollment by completing and submitting the Patient Enrollment Form. For your convenience, there are 2 ways to complete and submit the Patient Enrollment Form:

What happens next:

  • Once enrolled, your patient will receive a welcome call from a PAL
  • Your office will also receive communications from the Horizon By Your Side team on next steps
  • Your practice may need to complete several steps to obtain approval for TEPEZZA

*The Horizon Commercial Co-Pay Program may be available to patients who meet the following minimum criteria:

  • Patient’s prescription cannot be paid in part or in full by any government-funded program including but not limited to: Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, Department of Defense (DOD), TRICARE, or any state, patient foundation, or other pharmaceutical program
  • Patient is prescribed a covered Horizon rare disease medication for an indication approved by the Food and Drug Administration; the indication for each product is shown in its prescribing information
  • Patient is a resident of the United States
  • Patient must be commercially insured and have financial responsibility for a portion of the drug and/or infusion cost if applicable

The assistance offered under this co-pay program is subject to additional terms and conditions, including but not limited to the following:

Terms and Conditions: Offer cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription. Not valid for prescriptions reimbursed in whole or in part by any government-funded program including but not limited to Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, DOD, TRICARE, or any state, patient foundation, or other pharmaceutical program. Offer good only in the United States at participating specialty pharmacies or sites of care. Offer not valid where otherwise prohibited by law, for example by applicable state law prohibiting co-pay cards. Horizon reserves the right to rescind, revoke, or amend offer without notice. The selling, purchasing, trading, or counterfeiting of any co-pay card or benefits is prohibited by law. This co-pay program is not insurance and is not intended to substitute for insurance. Age for eligibility is dependent on product indication.

Participating Pharmacies or Healthcare Providers: By using this co-pay program, you acknowledge and confirm that the prescription will not be reimbursed in whole or in part by any government-funded program (such as, without limitation, Medicare, Medicaid, VA, DOD, TRICARE) and the patient and prescription meet the eligibility criteria set forth in the terms and conditions. You are responsible for reporting the receipt of the co-pay program benefits as required by an insurer, payer, or applicable law or regulation.

Patients: By enrolling in this co-pay program, you acknowledge and confirm that you and the prescription meet the eligibility requirements set forth in the terms and conditions, including that the prescription will not be reimbursed in whole or in part by any government-funded program (such as, without limitation, Medicare, Medicaid, VA, DOD, TRICARE). You may not seek any claims to government payers or other payers or insurers for this prescription. You may not seek reimbursement from any health savings, flexible savings, or other healthcare reimbursement account for any amounts received from the co-pay program. You are responsible for reporting the receipt of the co-pay program benefits as required by an insurer, payer, or applicable law or regulation.

Please note that independent foundations establish, administer, and implement the funds, which are separate and apart from Horizon.
While we cannot guarantee access or reimbursement for our medicines, we can educate you and your staff about gaining access to the medicine and various patient financial support programs.

Together, we can advocate for your patients to gain access to the medicines you believe will improve their lives.

Find out more at HorizonByYourSide.com

INDICATION AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, and dry skin.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

Please see Full Prescribing Information for more information.

INDICATION AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Infusion Reactions: TEPEZZA may cause infusion reactions. Infusion reactions have been reported in approximately 4% of patients treated with TEPEZZA. Reported infusion reactions have usually been mild or moderate in severity. Signs and symptoms may include transient increases in blood pressure, feeling hot, tachycardia, dyspnea, headache, and muscular pain. Infusion reactions may occur during an infusion or within 1.5 hours after an infusion. In patients who experience an infusion reaction, consideration should be given to premedicating with an antihistamine, antipyretic, or corticosteroid and/or administering all subsequent infusions at a slower infusion rate.

Preexisting Inflammatory Bowel Disease: TEPEZZA may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with IBD for flare of disease. If IBD exacerbation is suspected, consider discontinuation of TEPEZZA.

Hyperglycemia: Increased blood glucose or hyperglycemia may occur in patients treated with TEPEZZA. In clinical trials, 10% of patients (two-thirds of whom had preexisting diabetes or impaired glucose tolerance) experienced hyperglycemia. Hyperglycemic events should be managed with medications for glycemic control, if necessary. Monitor patients for elevated blood glucose and symptoms of hyperglycemia while on treatment with TEPEZZA. Patients with preexisting diabetes should be under appropriate glycemic control before receiving TEPEZZA.

Adverse Reactions

The most common adverse reactions (incidence ≥5% and greater than placebo) are muscle spasm, nausea, alopecia, diarrhea, fatigue, hyperglycemia, hearing impairment, dysgeusia, headache, and dry skin.

INDICATION

TEPEZZA is indicated for the treatment of Thyroid Eye Disease.

Please see Full Prescribing Information for more information.